Rifamycin derivatives active against pathogenic rapidly-growing mycobacteria.

导出原文传递

翻译打印收藏纠错

第一作者： Keith D,Combrink

第一单位： Department of Biology and Chemistry, Texas A&M International University, Laredo, USA. Electronic address: keith.combrink@blinn.edu.

作者： Keith D,Combrink ^[1] ; Andrea Ramirez,Ramos ^[2] ; Stephanie,Spring ^[2] ; Sebastian,Schmidl ^[2] ; Kira,Elizondo ^[2] ; Petronilo,Morin ^[2] ; Bryant,De Jesus ^[2] ; Florian P,Maurer ^[3]

作者单位： Department of Biology and Chemistry, Texas A&M International University, Laredo, USA. Electronic address: keith.combrink@blinn.edu. ^[1] Department of Biology and Chemistry, Texas A&M International University, Laredo, USA. ^[2] National and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany; University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[3]

关键词 Abscessus Chelonae Fortuitum Mycobacterium RGM

主题词抗菌药(Anti-Bacterial Agents);微生物敏感性试验(Microbial Sensitivity Tests);分子结构(Molecular Structure);分枝杆菌属(Mycobacterium);利福霉素类(Rifamycins);构效关系(Structure-Activity Relationship)

DOI 10.1016/j.bmcl.2019.07.001

PMID 31281018

发布时间 2020-10-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交